Inogen, Inc. (INGN) Research

Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.

Market snapshot

Symbol
INGN
Price
$6.41
Day change
+0.63%
Market cap
$173.5M
P/E ratio
-7.03x
52-week range
5.34-9.13
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$26.00

Peer companies

  • Perspective Therapeutics, Inc. (CATX)
  • Eupraxia Pharmaceuticals Inc. (EPRX)
  • Health Catalyst, Inc. (HCAT)
  • Solana Company (HSDT)
  • Nano-X Imaging Ltd. (NNOX)
  • Outset Medical, Inc. (OM)
  • Quanterix Corporation (QTRX)
  • Sight Sciences, Inc. (SGHT)

Recent insider activity

  • Sahney Mira Kirti — A-Award (28081 shares) on 2026-06-05
  • Jamali Vafa — A-Award (28081 shares) on 2026-06-05
  • Boehnlein Glenn S — A-Award (28081 shares) on 2026-06-05
  • Rider Heather D. — A-Award (28081 shares) on 2026-06-05
  • Mora Elizabeth — A-Award (28081 shares) on 2026-06-05

Open Inogen, Inc. (INGN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.